Skip to main content

Enveric Biosciences, Inc. (ENVB) Stock

Enveric Biosciences, Inc. Stock Details, Movements and Public Alerts

Stock Details

Enveric Biosciences, Inc. (ENVB), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $1.90. Over the past 52 weeks, it has ranged between $1.82 and $22.20. This places the current price at 8.6% of its 52-week high and 4.4% above its 52-week low. Recent trading volume was recorded at 22,407. The 14-day Relative Strength Index (RSI) stands at 34.32, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $3.90 by 51.28%. Similarly, it is below its 200-day moving average of $9.72 by 80.45%. The MACD histogram is 0.03, indicating bullish momentum (MACD Line: -0.53, Signal Line: -0.56).

52-Week Range

$22.20 - $1.82

-91.44% from high · +4.40% from low

Avg Daily Volume

988,735

20-day average

100-day avg: 776,885

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

0.00

Below market average

Forward P/E

-1.35

Earnings expected to grow

Price to Book

0.28

EV/EBITDA

0.28

EPS (TTM)

$1,390.68

Beta

0.30

Less volatile than market

Q:How is ENVB valued relative to its earnings and growth?
Enveric Biosciences, Inc. trades at a P/E ratio of 0.00, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong. Looking ahead, the forward P/E of -1.35 is lower than the current P/E, indicating analysts expect earnings to grow over the next year.
Q:What is ENVB's risk profile compared to the market?
With a beta of 0.30, Enveric Biosciences, Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 0.28 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-9,510,491

Return on Equity

-262.78%

Return on Assets

-133.22%

Q:How profitable and efficient is ENVB's business model?
Profitability metrics are not available for this stock.
Q:What are ENVB's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$2.6M

Shares Outstanding

1.39M

Book Value/Share

$6.67

Asset Type

EQUITY

Q:What is ENVB's market capitalization and position?
Enveric Biosciences, Inc. has a market capitalization of $2.6M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 1.39M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does ENVB's price compare to its book value?
Enveric Biosciences, Inc.'s book value per share is $6.67, while the current stock price is $1.90, resulting in a price-to-book (P/B) ratio of 0.28. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Mar 15, 2026, 02:33 AM

Technical Indicators

RSI (14-day)

34.32

Neutral

50-Day Moving Average

$3.90

-51.28% below MA-50

200-Day Moving Average

$9.72

-80.45% below MA-200

MACD Line

-0.53

MACD Signal

-0.56

MACD Histogram

0.03

Bullish

Q:What does ENVB's RSI value tell investors?
The RSI (Relative Strength Index) for ENVB is currently 34.32, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret ENVB's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.53 above the signal line at -0.56, with histogram at 0.03. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($3.90) is below the 200-day MA ($9.72), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Feb 23, 2026, 12:57 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for ENVB and get notified when the price changes.

Stay Ahead of the Market with Enveric Biosciences, Inc. Alerts

Set up price alerts for Enveric Biosciences, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.